Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 8OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Breast Neoplasms 16Neoplasms 4Neoplasm Metastasis 4Prostatic Neoplasms 3Multiple Myeloma 3Giant Cell Tumor of Bone 3Carcinoma, Renal Cell 3Smoldering Multiple Myeloma 2Recurrence 2Osteoporosis 2Melanoma 2Kidney Neoplasms 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Cancer Metastatic 1Parathyroid Neoplasms 1Osteoporotic Fractures 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplastic Cells, Circulating 1Musculoskeletal Pain 1Mastocytosis, Systemic 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hyperparathyroidism, Primary 1Granuloma, Giant Cell 1Giant Cell Tumors 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Denosumab × Clear all
NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
300 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT01624766 2021-02-25

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

M.D. Anderson Cancer Center

Phase 1 Completed
57 enrolled

Neoplasm Metastasis, Neoplasms, Recurrence

NCT01545648 2020-01-02

Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer

University of California, San Francisco

Phase 2 Terminated
4 enrolled 7 charts
Tumor-Agnostic

Neoplasms

NCT03415477 2018-01-30

Deno-ABC

Peking University People's Hospital

Phase 1/2 Completed
6 enrolled

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡